Subject Index For Volume 40  by unknown
Subject Index For Volume 40
Aborigines, renal biopsy findings (abst) 570
Acanthocyturia, glomerular bleeding 115
Acetate dialysate, effects on TGF/31, IL-i, /32m 1110
Acetate-free biofiltration, sodium modeling 525
Acid-base balance, renal ammoniagenesis and K
depletion 772
Acidification, furosemide (abst) 359
Acidosis
ammoniagenesis in metabolic 961
chronic uremia, low protein diets and metabolic 779
distal tubular renal, transplantation (abst) 359
Acquired cystic kidney disease
Nephrology Forum 143
renal failure (abst) 356
Acquired immunodeficiency syndrome
clinical features 35:S-13
nephropathology of HIV-1 35:S-19
renal lesions (abst) 357
Acute interstitial nephritis, nephropathia epidemica . 35:S-62
Acute renal failure
complement activation 1069
diclofenac-associated interstitial mucinosis (abst) 565
dopamine and ANP 21
epidermal growth factor, amikacin 691
hemorrhagic fever 35:S-54, S-62, S-72, S-80
induced by cancer therapy 309
lactate absorption, CAVHD (abst) 565
nonionic radiocontrast media (abst) 366
red cell trapping, RBF in cortex and medulla 625
therapy, CAVHD (abst) 362
Adenosine, metabolism of PAN by glomeruli 35
ADPKD
acquired cystic kidney disease 143
clues to pathogenesis 989
proteinuria, FGS (abst) 373
renal, cardiovascular, hormonal characteristics 501
treatable complications (abst) 561
ADPase, glomerular activity, endotoxin (abst) 979
Adrenal origin of arteral hypertension (abst) 352
Adrenergic modulation of K in ESRD 1103
Aging, insulin secretion impairment 662
Albumin in diabetes 923
Albuminuria
blood pressure (abst) 569
diuretic resistance 419
enzymatic defect of PMN in anti-GBM nephritis
(abst) 974
Aldose reductase, Ang II in diabetics (abst) 977
Aldosterone, release from adrenal gland, Ang II 583
Allograft
detection of CMV DNA (abst) 568
hepititis B infection (abst) 557
progressive function decline, histopathology 514
survival, antiidiotypic antibodies 80
Alpha/3-crystallin expression in the kidney 52
Alport syndrome
gene for Goodpasture antigen (abst) 565





iron uptake (abst) 378
overload risk (abst) 351
Amikacin, epidermal growth factor 691
Amino acids, salt, renal functional reserve 1134
Ammonia transport, electrophysiology in PST 1082
Ammoniagenesis
in metabolic acidosis 961
potassium depletion 772
Amphotericin B nephrotoxicity, salt loading 302
Amyloid AA detection (abst) 976
Amyloidosis
/32m in dialysis (abst) 356
carpal tunnel syndrome (abst) 366
cellular, humoral immunity in f32m (abst) 375
AN69 dialyzer
anaphylactoid reactions 1148
membrane, urea kinetics (abst) 371
Analbuminuric rats, LCAT (abst) 347
Analgesic abuse in 7275 working women 728
ANCA ELISA, diagnosis of vasculitis (abst) 564
Anemia
bone marrow changes with EPO treatment 917
deferroxiamine therapy (abst) 354
desferroxamine in dialysis (abst) 350
erythropoietin therapy (abst) 374
hepatitis B vaccination, rHuEPO treatment, dialysis . . 121
in BEN 34:S-46
organ distribution of EPO mRNA 69
rHuEPO (abst) 368
related to BEN 34:S-44
Angioplasty
hemodialysis fistula stenosis 91
percutaneous transluminal in RAS (abst) 351
renal artery stenosis, one kidney (abst) 364
Angiotensin II
actions in the kidney 583
diabetes mellitus (abst) 572
inhibits ANP mesangial cGMP accumulation 188
proteinuria and ACE! 734
thromboxane and hemodynamics 1090
Angiotensin converting enzyme inhibition
glomerular lesions 195
proteinuria and Ang II 734
proteinuria, nephropathies in CRF (abst) 374
Anti-DNA monoclonal antibodies (abst) 975
Anti-ETO IgE, dialysis (abst) 377
Anti-GBM nephritis
enzymatic defect of PMN, albuminuria (abst) 974
Anti-gp330 antibodies, passive HN (abst) 342
Anti-gp330 autoantibodies, proteinuria in HN (abst) .... 344
Anti-hepatitis C virus, transplantation (abst) 376
Anti-rat thymocyte serum
mesangial cell lysis and proliferation, hemodynamics.. 705
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Antibodies
anti-GBM, plasma exchange in FNGN 757
anti-OKT3 in transplant (abst) 361
anticoagulant-type, SLE (abst) 352
antiidiotypic, transplantation 80
hepatitis B vaccination, rHuEPO treatment in
dialysis 121
polyarteritis (abst) 573
production, secondary hyperparathyroidism 862
Anticoagulant, lipid concentrations in dialysis, LMWH.. 496
Antigens
hepatitis B virus, natural course in adults 35:S-40
human, 7-SQ/A (abst) 563
tubulointerstitial nephritis distribution 838
viral-induced immune complex disease 35:S-5
Antihypertension treatment, renal functional reserve.... 406
Antilymphocyte B antibodies, DDT (abst) 361
Antivirus C antibodies, HD (abst) 354
Apnea, sleep; BCAA in CRF 539
Apolipoprotein
gene expression in Heymann nephritis (abst) 978
metabolism in proteinuria 129
Arginine vasopressin
diabetes insipidus (abst) 345
effect of TMB-8 in CCD 434
Arterio-venous access, blood viscosity (abst) 566
Ascites, cirrhosis, endothelin treatment 182
Aspirin
effect on arterial ectonucleotidases (abst) 974
glomerular hyperfiltration (abst) 977
urea clearance, dialyzer fiber clotting (abst) 560
Atrial natriuretic peptide
dopamine in ARF 21
endothelin 1
mechanism of Ang II, cGMP accumulation 188
Autoantibodies
anti-interleukin-la in hemodialysis patients 787
Autoimmunity, excretion of C5b-9 in MGN 533
Autonomic dysfunction in CRF 489
B cell
immunoglobulin production, PTH, RF 96
murine host-versus-graft disease 852
secondary hyperparathyroidism 862
132-microglobulin
acetate dialysate effect on TGF/31 1110
altered excretion an index of nephrotoxicity
in BEN 34:S-18
early detection of BEN 34:S-41
early detection of tubular dysfunction in BEN. . . . 34:S-l5
immunohistology in BEN 34:S-68
in lymphocytes post-exposure to Cuprophan
membrane 285
pathogenic role of LMWP in BEN 34:S-89
patient and healthy family BEN members 34:S-21
small molecule and ion binding, BEN 34:S-85
studies in BEN 34:S-38
f32-microglobulinemia, anemia and BEN 34:S-44
132-microglobulinuria
in BEN 34:S-35
predictor of death in BEN 34:S-32
Ba, complement fragment in renal failure 939
Balkan endemic nephropathy
altered 2m excretion index of nephrotoxicity . . . . 34:S-18
anemia 34:S-44, S-46
/32-microglobulin 34:S-38
/32-microglobulin, early detection 34:S-4l
chromosome aberrations 34:S-97
early detection of tubular dysfunction 34:S-15




healthy and patients, f32m 34:S-2l
immunohistology 34:S-68
inferences of /32-microglobulinuria 34:S-35
light and electron microscopic studies 34:S-57
low molecular weight proteins 34:S-89
overview 34:S-l
papillary transitional cell tumors 34:S-77
partial LCAT deficiency 34:S-l02
predictor of death, /32-microglobulinuria 34:S-32
protein excretion 34:S-52
protein excretion in children of BEN families . . . . 34:S-27
renal function 34:S-49
selenium deficiency 34:S-12
small molecule and ion binding to f32m 34:S-85
tumors in urinary organs 34:S-75
urinary f32m excretion an index of nephrotoxicity . 34:S-18




Benazepril, chronic renal disease (abst) 570
Bicarbonate
biofiltration (abst) 349
skeletal muscle intracellular pH (abst) 559
Binding protein, TNFa 1166
Biofiltration, bicarbonate (abst) 349
Biopsy
findings in Australian Aborigines (abst) 570
histopathology of allograft chronic rejection 514
light and electron microscopy studies in BEN . . . . 34:S-57
Blood
acanthocyturia, glomerular bleeding 115
cell volume, post-transplant erythrocytosis 1153
viscosity, A-V access in HD (abst) 566
Blood flow
ammoniagenesis and chronic K depletion 772
hemodialysis fistula stenosis, angioplasty 91
red cell trapping, postischemic renal BF in cortex &
medulla 625
reduced, characteristics of ADPKD in young adults... 501
Blood pressure
albuminuria (abst) 569
characteristics of ADPKD in young adults 501
Bone
aluminum content (abst) 379
calcemic response to PTH in RF 1154
marrow, erythropoietin treatment changes 917
Branched-chain amino acid
in CRF patients, sleep and respiration 539
Brush border membrane
renal water channel, 30 kD protein (abst) 343
Brush border proteins in urine 823
CAPD
carpal tunnel syndrome (abst) 368
catheter related infection (abst) 369
computer simulations of peritoneal fluid transport .... 315
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cytotoxicity of PD fluids, L-929 cells 77
disposable non-disconnect Y-sy stem catheter (abst). . . 365
glucose polymers and PMO (abst) 978
hemostasis, platelet aggregation (abst) 371
lymphatic removal of dialysate 174
peritoneal sclerosis (abst) 566
peritonitis (abst) 369, 557
rHuEPO (abst) 368
vitamin D production (abst) 364
CAVHD
in severe ARF (abst) 362
lactate absorption (abst) 565
COL4A5 gene in Alport syndrome (abst) 980
Cadmium, lead, BEN 34:S-4
Calcitonin
calcemic response to PTH 219
sigmoidal relationship between Ca and 700
Calcitriol
calcemic response to PTH 1055
parathyroidectomy, calcemic response to PTH 1063
pulse therapy, HD osetitis fibrosa (abst) 377
subfractions in uremic plasma ultrafiltrate 868
Calcium
absorption in CCD (abst) 346
antagonist therapy, CsA nephrotoxicity (abst) 355
cytosolic in LLC-PK1 cells, PAF, TXA2 1075
effect of TMB-8 in CCT 434
sigmoidal relationship between calcitonin and 700
transport, vitamin D 1177
Calcium acetate dialysate (abst) 351
Cancer
therapy induces ARF 309
urinary organ tumors in BEN 34:S-75
Candida albicans, elimination from kidneys (abst) 400
Canine hereditary nephritis (abst) 558
Captopril
duplex Doppler (abst) 365
essential hypertension (abst) 351
rejection (abst) 354
renal oxidative injury (abst) 563
Carboxyethylgermanium sesquioxide, Ge02 882
Cardiac
function, rHuEPO (abst) 367
ischemic mortality, transplantation (abst) 564
low dose erythropoietin (abst) 367
renal disease, role of RAS (abst) 571
surgery in HD (abst) 351
Cardiovascular
abnormalities, pheochromocytoma diagnosis 544
analgesic abuse and renal disease 728
anaphylactoid reactions with AN69 dialyzer 1148
aspirin, arterial ectonucleotidases (abst) 974
sodium modeling in hemodiafiltration 525
Carpal tunnel syndrome
amyloidosis in HD (abst) 366
effect on CAPD (abst) 368
effect on HD and CAPD (abst) 368
Catecholamine, pheochromocytoma 544
Catheter
complication of central venous (abst) 367
disposable, non-disconnect Y-system in CAPD (abst) . 365
double lumen (abst) 365
peritoneal dialysis infections 1160
subclavian vein infections prevented 934
swan neck (abst) 370
urea kinetics with AN69 (abst) 371
Cells
human kidney, CMV infection 954
liver endothelial, IgA-IC (abst) 347
mesangial, structure and function in remnant kidney.. 226
myosin heavy and light chains in mesangial 1013
proximal tubule, culture (abst) 571
tubular epithelial, TNFa 203
visceral epithelial, T-SV4O 906
C5b-9 complex, MGN 533
C-erb B-2 amplification in cystic renal disease 509
Childhood nephrotic syndrome, cause of MesPGN
(abst) 561
Children
clinical features of HBV 30:S-42
kindergarten screening for renal diseases (abst) 562
liver transplantation (abst) 355
long-term results of transplantation 752
outcome in adolescents with ESRD 948
protein excretion, BEN families 34:S-27
renovascular hypertension (abst) 358
with HBV infection 35:S-31
Cholesterol, HDL, partial LCAT deficiency
in BEN 34:S-102
Chromosome
aberrations in BEN 34:S-97
pathogenesis of PKD 989
Chronic rejection, histopathology 514
Chronic renal failure
analgesic abuse in 7275 women 728
anemia and deferoxiamine (abst) 354
autoantibodies against IL-la in HD 787
benazepril (abst) 570
calcitonin, PTH 219
catheter replacement, infections 1160
characteristics of ADPKD in young adults 501
dialysis, transplantation, autonomic dysfunction 489
dietary protein restriction, Nephrology Forum 326
hyperparathyroidism (abst) 378
immunoglobulin production inhibition by PTH 96
insulin secretion impaired with aging 662
insulin secretion, K 413
insulin-like growth factor (abst) 572
iron (abst) 568
organ distribution of EPO mRNA 69
primary and secondary roles of viruses 35:S-2
protein excretion in children from BEN families . . 34:S-27
proteinuria, ACE! (abst) 374
recombinant human growth hormone in children
(abst) 356
renal function in BEN 34:S-49
secondary hyperparathyroidism 862
secondary hyperparathyroidism (abst) 372
sleep, respiration, BCAA 539
subfractions in uremic plasma ultrafiltrate 868
uremic toxin 461
Chronic renal insufficiency
calcemic response to PTH 1154
changes in daily protein intake (abst) 977
fenoldopan (abst) 371
Cimetidine, glomerular filtration 1171
Cirrhosis, natriuretic effects of endothelin 182
Cisplatin
gentamicin neprotoxicity, PAF 742
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nephrotoxicity, glycine 273
Cisplatinum, nephrotoxicity, PAF (abst) 376
Citric acid metabolism in hyperparathyroidism (abst) ... 366
Class 11 gene products, MHC-A/3 139
Clearance
deterioration of GFR in IgAN 1050
peritoneal equilibrium test (abst) 374
predicted for creatinine (abst) 561
Coal deposits and Balkan endemic nephropathy 34:S-9
Collagen cell matrix, mesangial cell behavior 653
Complement
activation by IgA (abst) 975
activation, ischemic renal failure 1069
fragment Ba in RF 939
regulatory factor (GCRF) in epithelial cells 668
synthesis in PTEC by IL-2 (abst) 342
urinary excretion of C5b-9 in MGN 533
Computer
simulations in CAPD 315
sodium modeling in hemodiafiltration 525
Cortex
red cell trapping, renal blood flow, medulla 625
Cortical collecting tubules
effect of TMB-8 434
potassium permeable channels 441
Countertransport, sodium-lithium in red cells of IgAN . 1118
51Cr-EDTA clearance, GFR in IgAN 1050
Creatinine
anemia and BEN 34:S-44
deterioration of GFR in IgAN 1050
histopathology of allograft rejection 514
marker of GFR, cimetidine 1171
predicted clearance (abst) 561
Cryofixation
rapid-freeze, freeze-substitution, slit diaphragms 621
Crystallin, expression of a/3 in kidney 52
Cuprophan membrane
compared with polysulfone 714
neutrophil binding to, complement receptors 1123
Cyclic-AMP
effect of TMB-8 in CCT 434
Cyclosporin A
blood lymphocytes, mRNA (abst) 573
calcium antagonist therapy (abst) 355
causes of anemia (abst) 360
dietary fish oil, transplantation (abst) 979
lipid metabolism (abst) 349
nephrotoxicity (abst) 370
plasma levels of cholesterol and triglycerides (abst). . . 360
postheparin lipolytic activity in transplants 720
reversal of hypertension (abst) 563
toxicity (abst) 558
transplantation (abst) 374
transplantation, HLA compatibility (abst) 353
tubulointerstitial lesions (abst) 373
Cyclosporine
elderly transplanted patients (abst) 350
fish oil ameliorates nephrotoxicity (abst) 347
glomerular barrier in NS (abst) 343
glomerular injury in heart transplant 243
production of TNFa and IL-la (abst) 975
Cystic renal disease
amplification of c-erb B-2 509
Cystinuria
sodium intake, amino acid excretion (abst) 364
Cysts
amplification of c-erb B-2 509
characteristics of ADPKD in young adults 501
Nephrology Forum 143
pathogenesis of PKD 989
proteoglycans in drug-induced renal cystic disease
(abst) 974
Cytokines
anti-interleukin- 1 a autoantibodies in HD patients 787
chemotactic, interleukin 8, mesangial cells 86
released by HMC stimulated by IL-8 597
role of TNF and IL-l in diabetic nephropathy 1007
Cytomegalovirus
detection in transplantation (abst) 362
detection of genome (abst) 353
in vitro human kidney cells 954
pathogenesis 35:S-8






hydrogen peroxide, LLC-PKI cells 891
Decay accelerating factor, epithelial cells 668
Deep etch, quick freeze method to fix slit diaphragms. . . 621
Delta-aminolevulinate dehydratase in BEN 34:S-93
Desferrioxamine
anemia in dialysis (abst) 350
test limitations (abst) 378
D-glucose
cotransporter, brush border proteins in urine 823
Diabetes
diet and drug therapy (abst) 362
fructosamine assay (abst) 358
mechanisms of hyperfiltration 792
microalbuminuric, aldose reductase (abst) 977
renal handling of C-peptide (abst) 345
urinary albumin, transferrin and iron excretion 923
Diabetes insipidus
arginine vasopressin binding to VI receptors (abst) ... 345
hydronephrosis (abst) 566
Diabetes mellitus
ammoniagenesis in metabolic acidosis 961
hypertension, microalbuminuria (abst) 346
non-insulin dependent, hyperinsulinemia (abst) 979
plasma Ang II and platelet receptor (abst) 572
racial differences 815
Diabetes, insulin dependent
diet, microalbuminuria (abst) 345
global GS and arteriolar hyalinosis 107
Diabetic nephropathy
role of TNF and IL-I 1007
survival (abst) 375
Dialysate
acetate, TGFB, IL-i and 132m 1110
aluminum (abst) 377
bicarbonate, pH (abst) 559
calcitriol, EPO, and IFN (abst) 369
calcium acetate (abst) 351
glucose polymers (abst) 978
hemofiltration using sterile infiltrate (abst) 560
lymphatic removal of 174
lymphatic removal of peritoneal 174
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sodium modeling 525
toxicity of peritonea!, fibroblasts L-929 77
Dialysis
anaphylactoid reactions with AN69 dialyzer 1148
anti-ETO IgE (abst) 377
autonomic dysfunction in CRF 489
f32m amyloidosis (abst) 356, 375
encephalopathy, Al overload (abst) 351
hepatitis B vaccination, rHuEPO treatment 121
hepatitis C (abst) 379, 560
interleukin-1, membranes (abst) 361
lipid concentrations, LMWH 496
membranes compared for intradialysis well-being 714
pericarditis (abst) 373
peritoneal, NZ survey (abst) 557
plasma exchange in FNGN, anti-GBM antibodies . . .. 757
platelet-derived thrombospondin 257





anaphylactoid reactions with AN69 1148
aspirin reduces fiber clotting (abst) 560
cuprophan, /32m stimulation 285
membrane reuse (abst) 560
reuse, effect on urea and 2m removal (abst) 566
Diaphragms, morphology of slit, QF-DE method to fix.. 621
Diatrizoate meglumine, nephrotoxicity in BEN 34:S-l8
Diclofenac-associated interstitial mucinosis (abst) 565
Diet
drug therapy and diabetes (abst) 362
growth, rHuEPO in children (abst) 566
hypoprotein, captopril (abst) 362
hypoprotein, TNF, PAF in NS (abst) 376
low protein, metabolic acidosis and uremia 779
microalbuminuria and diabetes (abst) 345
nephrectomy (abst) 345
protein restriction, CRF, Nephrology Forum 326
protein restriction, nephrotoxicity 57
sodium pump, uremia 238
Distal nephron, unilateral nephrectomy 62
Diuretics, albuminuria 418
Donor organs, availability (abst) 559
Dopamine
aldosterone, pregnancy (abst) 569
atrial natriuretic peptide in ARF 21
salt and RFR 1134
Drug therapy
prednisone in normal kidneys (abst) 978
Dry weight ion hemodialysis (abst) 350
DTPA clearance, renal function in BEN 34:S-49
Duplex scan
renal transplant (abst) 559
Eicosanoid and excretion, diet (abst) 342
Electrophysiology of ammonia transport in SPT 1082
End-stage renal disease
ACKD 143
adrenergic modulation of extrarenal K disposal in
men 1103
antiidiotypic antibody activity, transplantation 80
autopsy studies in BEN 34:S-57
c-erb B-2 in cystic renal disease 509
clinical features of HIV nephropathy 35:S-13
diabetic nephropathy, arteriolar hyalinosis 107
kinetics of rHuEPO (abst) 363
racial differences 815
therapy, ACE! 195
therapy, rHuEPO (abst) 363
End-stage renal failure
geochemistry of BEN 34:S-9
outcome for adolescents 948
plasma exchange in FNGN, anti-GBM antibodies . . .. 757
Endothelin
biological actions, pathophysiology
natriuretic effects, cirrhosis and ascites 182
Endotoxin, glomerular ADPase activity (abst) 979
Entactin
isolation, characterization and tissue distribution 643
Environment
coal deposits and BEN 34:S-9
lead, cadmium, BEN 34:S-4
selenium deficiency and BEN 34:S-l2
Enzymes
antioxidant, glucocorticoid 291
erythrocyte ALA-D in BEN 34:S-93
ornithine decarbosylaxase, mesangial cell
proliferation 684
proteolytic, mediate glomerular injury 161
Epidemiology of BEN 34:S-9
Epidermal growth factor, pathogenesis of PKD 989
Epinephrine, pheochromocytoma 544
Epithelial cells
cDNA sequence encoding MHC-Aj3 139
complement regulatory factor (GCRF) 668
distribution of G-proteins 997
human, CMV infection 954
hyperplasia, ACKD 143
hypoxia and reoxygenation 1041
membrane associated TNFa 203
metabolism of PAN by glomeruli 35
stable cell line of T-SV4O 906
Erythrocytes
acanthocyturia, glomerular bleeding 115
anion exchanger in uremia (abst) 357
Erythrocytosis, predictors of post-transplant 1153
Erythropoietin
anemia in BEN 34:S-46
cardiac function (abst) 367
dosage (abst) 574
low dose, cardiac function (abst) 367
mRNA, organ distribution 69
peritoneal behavior (abst) 377
therapy (abst) 349, 353, 355
treatment changes bone marrow 917
vasoactive hormones, BP, RD (abst) 568
Essential growth factor, vitamin D, renal growth 212
Essential hypertension, captopril therapy (abst) 351
European HFRS 35:S-80
Excretion
ammoniagenesis and chronic K depletion 772
angiotensin II and ACE!, proteinuria 734
of /32-microglobulinuria in BEN 34:S-35
potassium in men in ESRD 1103
protein in BEN patients 34:S-52
urinary, /32m in BEN 34:S-41
urinary, C5b-9 complex in MGN 533
urine glycosaminoglycans in NS 280
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Extracellular matrix
cystogenesis in PKD 989
mesangial cell behavior 653
mesangial proliferative nephritis 477
murine GvHD (abst) 344
PAN (abst) 558
pathogenesis of interstitial fibrosis in PAN 1020
Fc 7RII characteristics (abst) 567
Fenoldopan, progression of CRF (abst) 371
Ferric gluconate, iron deficiency in HD (abst) 353
Fetal outcome, pregnancy in IgAN 1098
Fibrinolysis
cyclosporine post-transplant (abst) 974
Fibroblasts, L-929, toxicity of dialysate 77
Fibronectin, mesangial cells (abst) 976
Fibrosis, interstitial, PAN 1020
Fish oil, transplantation, CsA nephrotoxicity (abst) 347
Fistula stenosis, HD, angioplasty 91
Focal necrotizing glomerulonephritis
plasma exchange without anti-GBM antibodies 757
Focal segmental glomerulosclerosis
interstitial fibrosis in PAN 1020
Fructosamine assay in diabetes (abst) 358
Furosemide
fluid balance (abst) 346
potency, albuminuria 418
urinary acidification, transplant (abst) 356
urinary blood pCO2 difference (abst) 359
G protein, distribution along nephron segments 997
Gaisbock erythrocytosis 1153
Gene
c-erb B-2 amplification in cystic renal disease 509
cDNA sequence encoding MHC-Af3 139
chromosome abberrations in BEN 34:S-97
expression of a/3-crystallin 52
expression, IL-2 and IFN-y in RF 266
expression, PAN nephrosis 874
for Goodpasture antigen (abst) 565
regulation, endothelin
Genetics
immuno-, in IgAN (abst) 573
pathogenesis of PKD 989
Gentamicin, cisplatin nephrotoxicity, PAF 742
Geochemistry
coal deposits and BEN 34:S-9
selenium deficiency and BEN 34:S-l2
Germanium dioxide, chronic tubulointerstitial changes . . 882
Gestation, pregnancy in IgAN 1098
Glomerular basement membrane
antibodies, plasma exchange in FNGN 757
antiserum vs. TNFa, glomerular injury 32
proteolytic enzymes mediate glomerular injury 161
Glomerular epithelial cells
complement regulatory factor (GCRF) 668
Glomerular filtration rate
actions of Ang II 583
characteristics of ADPKD in young adults 501
cimetidine, creatine marker 1171
complement activation in ischemic RF 1069
deterioration in IgAN 1050
intraperitoneal 99mTcDTPA (abst) 567
mechanism of Ang II on ANP, cGMP accumulation .. 188
mechanisms of diabetic hyperfiltration 792
nephrotoxic serum nephritis 57
post-uninephrectomy 62
renal functional reserve and salt 1134
Glomerular permeability factor, T cell hybridomas 453
Glomerular plasma flow
gentamicin and cisplatin nephrotoxicity, PAF 742
Glomerulonephritis
acanthocyturia, glomerular bleeding 115
antiserum vs. TNFa, protease inhibitor, injury 43
children, RB V-associated 35:S-42
focal necrotizing, plasma exchange, antibodies 757
heart transplantation, CsA therapy, injury 243
hepatitis B associated 35:S-24
hepatitis B virus, natural course 35:S-40
hepatitis B, immunopathogenetics 35:S-34
human antigen, 7-SQ/A (abst) 563
incidence in Spain (abst) 349
interleukin-8, mesangial cells 86
interstitial leukocytic infiltration 425
macrophage phenotype (abst) 563
murine host-versus-graft disease 852
nephrotoxicity, Heymann nephritis 847
ornithine decarboxylase, mesangial cells 684
plasminogen activator (abst) 567
pregnancy in IgAN 1098
progress, neoplasms (abst) 379
proteolytic enzymes and glomerular injury 161
racial differences 815
role of T lymphocytes (abst) 572
tumor necrosis factor (abst) 572
Glomerulosclerosis
extracellular matrix 477
extracellular matrix (abst) 344
global, hyalinosis, !DDM 107
growth hormone and renal scarring 29
intersititial leukocytic infiltration 425
mesangial structure and function 226
nephropathology of HIV-1 35:S-19
role of "uremic toxins" 461
therapy, ACE! 195
Glucocorticoid, antioxidant enzymes, oxidant injury.... 291
Glycine, cisplatin nephrotoxicity 273
Glycosaminoglycans, urine in NS 280
Goodpasture syndrome
antigen in canine hereditary nephritis (abst) 558
type IV collagen (abst) 574
Growth
long-term results of transplantation in children 752
renal, Ang I! and mesangial cells 764
treatment with rHuEPO (abst) 566
Growth factor
PDGF B-chain mRNA in mesangial proliferative
nephritis 470
c-erb B-2 amplification in cystic renal disease 509
epidermal, amikacin 691
insulin-like, CRF (abst) 572
isolation of (abst) 370
regulation of IL-2 and !NF-y in RF 266
vitamin D and compensatory 212
Growth hormone
experimental renal scarring 29
hyperfiltration, RPF (abst) 342
steroid-induced growth depression, health and
uremia 1032
uremic growth failure (abst) 375
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Guanine nucleotide binding proteins, distribution in
nephron 997
Hantavirus
clinical features, Europe 35:S-80
clinical features, Korea 35:S-88
hemorrhagic fever with renal syndrome 35:S-54
mechanisms of hemorrhagic fever with renal
syndrome 35:S-72
Heart transplantation, glomerular injury by CsA 243
Hematuria
acanthocyturia, glomerular bleeding 115
proteinuria post-exercise (abst) 365
Hemodiafiltration, sodium modeling 525
Hemodialysis
acetate dialysate, B!, IL-I, 2m 1110
aluminum (abst) 378
anaphylactoid reactions with AN69 dialyzer 1148
anti-hepatitis C antibodies (abst) 361
anti-interleukin- 1 a autoantibodies 787
antivirus C antibodies (abst) 354
autonomic dysfunction in CRF 489
bone marrow changes with EPO treatment 917
calcitriol pulse therapy (abst) 377
cardiac surgery (abst) 351
carpa! tunnel syndrome (abst) 368
catheter complications (abst) 367
catheter replacement, infections 1160
catheters (abst) 365
complement activation, ischemic RF 1069
costs, EPO (abst) 569
dialyzer reuse (abst) 560
dry weight ion (abst) 350
erythropoietin therapy (abst) 349, 353, 355, 371
fistula stenosis, angioplasty 91
hemostasis and platelet aggregation (abst) 371
heparin and LMWH (abst) 357
hepatitis C virus (abst) 356
hypertension therapy (abst) 379
hypertension, venous, compliance (abst) 347
immunoglobulin, RF and PTH 96
leukocyte adhesion receptors on neutrophils 899
lipid concentrations, LMWH 496
low molecular weight heparin (abst) 360
lymphocytes (abst) 363
membranes compared 714
outcome in adolescents with ESRF 948
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